Skip to main content
Veterinary Medicines

OTOGENT

Authorised
  • Gentamicin sulfate
  • Flumetasone pivalate
  • Tetracaine hydrochloride
  • Econazole nitrate

Product identification

Medicine name:
OTOGENT
Active substance:
  • Gentamicin sulfate
  • Flumetasone pivalate
  • Tetracaine hydrochloride
  • Econazole nitrate
Target species:
  • Dog
  • Cat
Route of administration:
  • Auricular use

Product details

Active substance and strength:
  • Gentamicin sulfate
    833.00
    milligram(s)
    /
    100.00
    millilitre(s)
  • Flumetasone pivalate
    30.00
    milligram(s)
    /
    100.00
    millilitre(s)
  • Tetracaine hydrochloride
    500.00
    milligram(s)
    /
    100.00
    millilitre(s)
  • Econazole nitrate
    1.00
    gram(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Ear drops, solution
Withdrawal period by route of administration:
  • Auricular use
    • Dog
      • Unspecified
        0
        day
    • Cat
      • Unspecified
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QS02CA02
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet Productions S.r.l.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Productions S.r.l.
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 3/06/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."